SCHEDULE
OF COMPANY ISSUED COMMON STOCK
| | |
Number of shares | |
| Shares arising from stock-based compensation to executives | |
| 157,259 | |
| Issuance of shares in connection with sales made under private offerings | |
| 236,694 | |
| Consideration of the Option Agreement with Atlas Lithium | |
| 66,497 | |
| Total | |
| 460,450 | |
|
During
the year ended December 31, 2024, the Company issued 1,971,853
shares of common stock, as follows:
SCHEDULE
OF COMPANY ISSUED COMMON STOCK
| | |
Number of shares | | |
Cash received | |
| Shares arising from stock-based compensation to executives | |
| 181,748 | | |
| 13,500 | |
| Issuance of shares in connection with sales made under private offerings | |
| 250,764 | | |
| 1,582,250 | |
| Shares issued in connection with the merger | |
| 1,539,340 | | |
| - | |
| Total | |
| 1,971,853 | | |
| 1,595,750 | |
|